Substance
REVEFENACIN
Global reference: every product and company linked to this substance.
- cas: 864750-70-9
- ncit: C152200
- pubchem_cid: 11753673
- rxnorm: 2102775
- unii: G2AE2VE07O
BIPHENYL-2-YLCARBAMIC ACID, 1-(2-((4-(4-CARBAMOYLPIPERIDIN-1-YLMETHYL)BENZOYL)METHYLAMINO)ETHYL)PIPERIDIN-4-YL ESTER · GSK-1160724 · GSK1160724 · revefenacin [INN] · REVEFENACIN [USAN] · Revefenacin [WHO-DD] · TD-4208 · YUPELRI
Revenue by product (1)
| Company | Product | Latest period | Revenue |
|---|---|---|---|
| VIATRIS INC. COMMON STOCK | YUPELRI | Q2 2026 | $70.7M |
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (1)
- YUPELRI · VIATRIS INC. COMMON STOCK